Navigation Links
Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against 2012 Nobel Laureate Dr. Yamanaka for Deception
Date:5/15/2013

LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu , the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka , one of the winners of the 2012 Nobel Prize in Physiology or Medicine in the Superior Court of California, County of San Francisco. The lawsuit filed alleges, among other things, deception by Dr. Shinya Yamanaka .

(Photo: http://photos.prnewswire.com/prnh/20130515/LA14340)

According to Dr. Xu's attorney, a previous lawsuit was filed by Dr. Xu against the Nobel Assembly on December 3, 2012, urging the Assembly to clarify certain statements made in conjunction with awarding the 2012 Nobel Prize in Physiology or Medicine. Unfortunately, no response clarifying the truth about the science has been received as the case is still pending. Therefore, Dr. Xu has filed another lawsuit directly against Dr. Yamanaka, for alleged deceptive practices employed by Dr. Yamanaka.

Dr. Xu's attorney stated that Dr. Yamanaka's published statements labeling his artificially transgenic cell study as "induction of somatic cells into stem cells", which was the patented technology of Dr. Xu, has caused substantial damages to his reputation and company. Dr. Xu claims that Dr. Yamanaka has deceived a number of well-intentioned professionals into exploration and re
'/>"/>

SOURCE Mebo International; Ardent Law Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dr. Rongxiang Xu, Owner of Patented Technology to Regenerate Damaged Organs, Announces Lawsuit Against 2012 Nobel Laureate Dr. Shinya Yamanaka
2. PharmaDirections is Co-inventor on Second Issued Formulation Patent Entitled “Layered Pharmaceutical Formulations”
3. First patent issues on TAL effector technology
4. Wysebridge Patent Bar Review Supports the National Foundation for Celiac Awareness (NFCA) During Celiac Awareness Month
5. Provitro Biosciences Awarded First-Ever U.S. Patent For Large-Scale Production Of Bamboo Plants
6. mPhase Technologies Receives Issue Notification Of Key Patent
7. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
8. Stemedica Issued U.S. Patent For Ectodermal Stem Cells
9. Wysebridge Patent Bar Review Launches America Invents Act (AIA) Study Suite
10. Cancer Advances Announces Issuance of Three New Patents to Its Suite of Gastrin Inhibitor Products
11. DuPont Receives ‘Patents for Humanity’ Award for Groundbreaking Research to Improve Nutritional Profile of Staple Crop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 ... patient care in critical areas, announced the closing of an ... warrants to purchase up to an aggregate 3,500,000 shares of ... and $.01 per warrant.  The warrants have a per share ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 “Preparative ... Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, ... Food & Agriculture) - Forecasts to 2019” provides ... challenges, opportunities, current market trends, and strategies impacting ...
(Date:12/24/2014)... SoundConnect’s 2015 next ... edge communication technology, provide continued education and inform ... series demonstrates online communication features and benefits; empowering ... most innovative and powerful tools. , According to ...
(Date:12/24/2014)... The report provides basic information ... application and industry overview. This report also presents ... Production is separated by regions, technology and applications. ... downstream client survey, marketing channels, industry development trend ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... ... 20 Years of Experience to Biochemical Innovator, , ... Houston, TX (PRWEB) February 2, 2010 ... microbiology innovations that produce green chemicals, today announced the appointment of Daniel J. ...
... , EXTON, Pa. , ... Board: FCSC), a biotechnology company focused on the development ... applications, announced today that David Pernock , Chairman ... Executive Officer (CEO), effective immediately. Pernock most recently served ...
... , , ... February 2 Elbit Imaging,(NASDAQ: EMITF ) ("Elbit ... medical holdings (InSightec - 60%, and Gamida,Cell - 28%; both on ... offer shares of such subsidiary in a public offering on the,Tel ...
Cached Biology Technology:Glycos Biotechnologies Expands Management Team with Appointment of Vice President of Research and Development 2Glycos Biotechnologies Expands Management Team with Appointment of Vice President of Research and Development 3Fibrocell Science, Inc. Names David Pernock Chief Executive Officer 2Fibrocell Science, Inc. Names David Pernock Chief Executive Officer 3Elbit Imaging Evaluating Establishment of a Subsidiary to Hold its Bio-Tech and Medical Investments 2Elbit Imaging Evaluating Establishment of a Subsidiary to Hold its Bio-Tech and Medical Investments 3Elbit Imaging Evaluating Establishment of a Subsidiary to Hold its Bio-Tech and Medical Investments 4Elbit Imaging Evaluating Establishment of a Subsidiary to Hold its Bio-Tech and Medical Investments 5
(Date:12/19/2014)... Calif. , Dec. 18, 2014  23andMe, Inc., the leading ... that pinpoints fine-scale differences in genetic ancestry of individuals from ... Since immigrants first arrived more than four hundred years ago, ... a meeting place for peoples from different continents. This study ...
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. One major ... multimodal biometric systems. Multimodal biometric systems utilize more than ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Dr. Ann F. Jacobson, associate professor in Kent States ... initially choose to postpone but ultimately undergo total knee ... education before and after the procedure. ... post operative experiences with total knee replacement surgery, says ...
... 13, 2008.-Unlike most scientific and technological advances, which tend ... finds itself the center of public debate and regulatory ... many of its applications. , In this second ... first was in 2003), the sample has been enlarged ...
... . , A scientific group of the Universities of ... have deciphered for the first time fruit genomic sequence, in this ... issue of the prestigious journal Nature . One of the ... of the Department of Genetics of the ...
Cached Biology News:Research examines factors in delaying or declining total knee replacement surgery 2BBVA Foundation international study on attitudes to stem cell research 2BBVA Foundation international study on attitudes to stem cell research 3BBVA Foundation international study on attitudes to stem cell research 4BBVA Foundation international study on attitudes to stem cell research 5BBVA Foundation international study on attitudes to stem cell research 6Scientists decipher fruit tree genome for the first time 2Scientists decipher fruit tree genome for the first time 3
Monoclonal Antibody to GLP Immunogen: Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3)...
... In Vitro Transcription Kits synthesize RNA probes ... 9 cpm/g. High specific activity, single-stranded ... assays, in situ hybridization, and blot hybridizations. ... the synthesis of modest amounts of unlabeled ...
RAB32, member RAS oncogene family, mRNA (cDNA clone MGC:13500 IMAGE:4280407), complete cds...
Request Info...
Biology Products: